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Abstract 
Mycoplasma agalactiae, an important pathogen of small ruminants, exhibits a very 
versatile surface architecture by switching ON-OFF multiple, related lipoproteins 
(Vpmas). In the type strain, PG2, Vpma-phase variation is generated by a cluster of 6 
vpma genes that undergoes frequent DNA rearrangements via site-specific 
recombination. To further comprehend the degree of diversity that can be generated at 
the M. agalactiae surface, the vpma gene repertoire of a field strain, 5632, was analyzed 
and shown to contain an extended repertoire of 23 vpma genes distributed onto two loci 
located 250 kbp apart. Loci I and II include 16 and 7 vpmas, respectively, with all vpmas 
of locus II being duplicated at locus I. Several Vpmas displayed a chimeric structure 
suggestive of homologous recombination and a global proteomic analyses further 
indicate that at least 13 out of the 16 Vpmas can be expressed by the 5632 strain. 
Because a single promoter is present in each vpma locus, concomitant Vpma 
expression can occur in a strain with duplicated loci. Consequently, the number of 
possible surface combinations is much higher in 5632 compared to the type strain. 
Finally, our data suggested that insertion sequences are likely to be involved in 5632 
vpma locus duplication at a remote chromosomal position. The role of such mobile 
genetic element in chromosomal shuffling of genes encoding major surface components 
may have important evolutionary and epidemiological consequences for pathogens such 
as mycoplasmas that have a reduced genome and no cell wall. 
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Introduction 
Bacteria of the Mycoplasma genus belong to the Class Mollicutes and represent a 
remarkable group of organisms that derived from the Firmicutes lineage by massive 
genome reduction (41, 51). Consequent to this regressive evolution, modern 
mycoplasmas have been left with a small genome (580 to 1,400 kb), a limited number of 
metabolic pathways and no cell wall. Due to these particularities, members of the 
Mycoplasma genus have often been portrayed as "minimal self-replicating organisms". 
Despite this apparent simplicity, a large number of mycoplasma species are successful 
pathogens of man and a wide range of animals in which they are known to cause 
diseases that are often chronic and debilitating (1, 33). The surface of their single 
membrane is considered as a key interface in mediating adaptation and survival in the 
context of a complex, immunocompetent host (10, 13, 34, 40). Indeed, mycoplasmas 
possess a highly versatile surface architecture due to a number of sophisticated genetic 
systems that promote the intraclonal variation in expression and structure of abundant 
surface lipoproteins (9, 50). Usually, these systems combine a set of contingency genes 
with a molecular switch for turning expression ON or OFF that is either based (i) on 
spontaneous mutation (slipped strand mispairing), (ii) on gene conversion or (iii) on 
specific DNA rearrangements (9). While high-frequency phenotypic variation using the 
two first mechanisms has been thoroughly described in other bacteria (47), switching of 
surface components by shuffling silent genes at a particular single expression locus has 
mainly been studied in mycoplasmas (3, 8, 14, 16, 23, 39, 43). 
Mycoplasma agalactiae, an important pathogen responsible for contagious agalactia in 
small ruminants (listed by the world organization for animal health), possesses a family 
of lipoproteins encoded by the vpma genes which phase variation in expression is driven 
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by a “cut and paste” mechanism involving a tyrosine site-specific recombinase 
designated as Xer1 (16). Data previously gathered in the PG2 type strain had identified 
a single vpma cluster (42) composed of 6 vpma genes adjacent to one xer1 gene 
(Fig. 1A). Based on fine genetic analyses, Xer1 was further shown to mediate frequent 
site-specific DNA rearrangements by targeting short DNA sequences located upstream 
each vpma (8, 16). While some vpma rearrangements can be phenotypically silent, 
others result in Vpma ON/OFF switching by linking a silent vpma gene sequence 
immediately downstream to the unique vpma promoter. Because site-specific 
recombination can be reciprocal, the initial vpma configuration can be restored without 
loss of genetic information.  
The vsa family of the murine pathogen M. pulmonis (3, 39), the vsp family of the bovine 
pathogen M. bovis (2, 24), and the vpma family of M. agalactiae, all generate intraclonal 
surface diversity using a very similar molecular switch (23) although their overall coding 
sequences seem to be specific of one Mycoplasma species. DNA rearrangements also 
govern phase variation of the 38 mpl genes of the human pathogen, M. penetrans (27, 
35, 38). However, in this mycoplasma species the molecular switch is slightly different 
since each mpl gene possesses its own invertible promoter (19). In M. penetrans, the 
individual expression of each mpl gene can then be switched ON/OFF in a combinatory 
manner resulting in a large number of possible Mpl surface configurations. Since M. 
pulmonis, M. bovis and M. agalactiae all belong to the Mycoplasma hominis 
phylogenetic cluster (48) and are relatively closely related while M. penetrans belongs to 
the distinct Mycoplasma pneumoniae phylogenetic cluster (30, 48), it is tempting to 
speculate that the vsa, the vsp and the vpma systems have all been inherited from a 
common ancestor and that the bulk of their coding sequences has evolved 
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independently in their respective host while the molecular switch mechanism has been 
retained. 
In so-called “minimal” bacteria, the occurrence of relatively large genomic portions 
dedicated to multigene families, each encoding phase variable, related, surface proteins, 
suggests that they serve an important function(s). Data accumulated over the years in 
several mycoplasma species tend to indicate that one general purpose of these systems 
is to provide the mycoplasma with a variable shield that modulates surface accessibility 
in order to escape the host response and to adapt to rapidly changing environments (10, 
11, 13, 40, 50). On the other hand, the sequences of phase variable proteins are 
relatively conserved within one species but divergent between species, suggesting a 
more specific role for these molecules.  
The role of the Vpma family of M. agalactiae has yet to be elucidated but it was recently 
shown that Vpma switches in expression occur at a remarkably high rate in vitro, (10-2 to 
10-3 per cell per generation (8, 17). The vpma system described in PG2 (16) and in 
another M. agalactiae strain isolated in Israel (in which Vpma were designated as Avg 
(14)), both revealed a repertoire of 6 vpma genes and only one promoter, suggesting 
that in M. agalactiae the number of Vpma configurations is limited to 6. This contrast 
with the situation commonly found in other Mycoplasma variable systems that can offer 
larger mosaic of surface architecture because of the concomitant switches of several 
surface related proteins and/or because of a higher number of phase variable genes.  
To further understand the degree of diversity that can be generated at the surface of 
M. agalactiae, we analyzed the vpma gene content of a field strain, 5632, whose 
genome has recently been sequenced by our group (unpublished data). The present 
study shows that 5632 contains a total of 23 vpma genes distributed in two distinct loci 
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that both contain a recombinase gene. Further genomic and proteomic analyses indicate 
that the capacity of 5632 to vary its Vpma surface architecture is far more complex than 
that described for the type strain. Unlike PG2, both 5632 vpma loci are associated with 
several mobile genetic elements (IS) that could play an evolutionary role in the dynamics 
of vpma repertoires as suggested by data presented here. One 5632 vpma locus 
contains ORFs that are highly conserved in both M. bovis, a closely related bovine 
mycoplasma, and in the phylogenetically distant mycoplasmas of the mycoides cluster 
that are also important ruminant pathogens. Whether these have been acquired through 
evolution or through horizontal transfer will be discussed. The present study reveals an 
additional degree of complexity for the Vpma system and further suggests that some 
field strains might have a more dynamic genome and a more variable surface than was 
first estimated (42). 
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Materials and methods 
Bacterial strains, culture conditions and DNA isolation 
M. agalactiae type strain PG2, clone 55.5 (16) and strain 5632, clonal variant C1 (26), 
used in this study have been previously described. These strains have been 
independently isolated from goat in Spain. Experiments reported in this manuscript have 
all been performed with these clonal variants but for simplicity, we will further refer as 
the PG2 and the 5632 only. M. agalactiae field isolates were kindly provided by Dr. 
Poumarat (AFSSA Lyon, France) (see Table S1 in the supplemental material). 
Mycoplasmas were propagated in SP4 liquid medium (46) at 37°C and genomic DNA 
was extracted as described elsewhere, (7, 37). 
 
Identification of M. agalactiae vpma and associated loci 
Whole genome sequencing of strain 5632 (clonal variant C1) was performed as follows. 
A library of 3 kb inserts (A) was generated by mechanical shearing of the DNA followed 
by cloning of the blunt end fragments into the pcDNA2.1 (Invitrogen) E. coli vector. Two 
libraries of 25 kb (B) and 80 kb (C) inserts were generated by HindIII partial digestion 
and cloning into the pBeloBAC11 (CALTECH) modified E. coli vector. The plasmid 
inserts of 10752, 3072 and 768 clones picked from the libraries A, B and C, respectively, 
were end-sequenced by dye-terminator chemistry on ABI3730 sequencers. The 
PHRED/PHRAP/CONSED software package was used for sequence assemblies. Gap 
closure and quality assessment were made according to the Bermuda rules with 10307 
additional sequences. The vpma loci of 5632 were detected by DNA homologies to that 
previously described of PG2 (positions of the loci on the 5632 genome are given in the 
text with reference to the first nucleotide of the dnaA gene as nucleotide 1) and were 
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annotated using the CAAT-Box platform (15) with the aid of the Artemis software (36) 
and the ACT software (5). The BLAST program suite was used for sequence homology 
searches in non-redundant databases (http://www.ncbi.nlm.nih.gov/blast/blast.cgi). In 
order to determine the extent of sequence similarity, alignments between sequences 
were performed using softwares Needle (Needleman-Wunsch global alignment 
algorithm) and Water (Smith-Waterman local alignment algorithm) 
(http://www.ebi.ac.uk/Tools/emboss/align/). Designation of 5632 vpma genes was based 
on local and global alignment scores using all vpma gene sequences including those 
previously described in PG2. A same name was attributed to vpma presenting an amino-
acid identity > 50% in global alignment (Needle) and an amino-acid identity >70% in 
local alignment (Water). Using these rules, strain 5632 was found to contain the vpmaW 
and vpmaX genes also present in PG2. As well, a distinct name was given to vpmaY 
and vpmaF although they display a global identity >50% because their local identity is 
<70%. vpma products with highly similar sequences that only differed in the number of 
their C-terminal repeats were considered as allelic versions and designated with a same 
letter followed by a different number (i. e. VpmaD1 and VpmaD2 and, VpmaF1 and 
VpmaF2). Finally, vpmaI was not considered as an allelic version of vpmaD because the 
C-terminal repeated region of its corresponding product displayed a local identity of 
64.7% (<70%) with VpmaD1 and D2 couterparts.  
Direct sequencing of PCR products and of genomic DNA (18, 20) was performed using 
specific primers (see Table S2 in the supplemental material) at the sequencing facility of 
UMR 5165 (CNRS, UPS, CHU Purpan, Toulouse, France). 
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Phylogenetic analyses were performed using MEGA 3.1 (21) and the Neighbor-Joining 
tree method. The reliability of the tree nodes was tested by performing 500 bootstrap 
replicates. 
Accession number for locus I5632 and locus II5632 are, respectively, FP245515 and 
FP245514 
 
PCR assays 
PCR assays were performed on an Eppendorf Mastercycler ep-Gradient thermocycler 
using 5 ng M. agalactiae DNA as template with specific primers (see Table S2 in the 
supplemental material). PCR assays were performed in 25 μL reaction mixtures 
containing 0.4 mM of each primer, PCR reaction buffer (with MgSO4, New England 
Biolabs [NEB]) ) at 1X final concentration, 200 mM dNTPs and 2.5 U Taq DNA 
polymerase (NEB). Reaction mixtures were subjected to 2 min at 94°C, 30 cycles of 30s 
at 94 °C, 30s at 55°C, 30s at 72 °C, and a final elongation step of 5 min at 72°C. All 
PCR assays were performed at the unique annealing temperature of 55°C using primer 
pair xerF/phydR for specific amplification of locus I; primer pairs xerF/agpR or Mag2F/ 
agpR for locus II; primer pairs aip1F/aip1R for the abiGI gene; primer pairs aip2F/aip2R 
for the abiGII gene. PCR products were analyzed by gel electrophoresis in 1% agarose.  
 
Colony immunoblotting and proteomic analyses 
Colony immunoblottings were performed as previously described (8). Briefly, 
nitrocellulose membranes were placed on mycoplasma colonies freshly grown on the 
agar medium, then removed and rinsed three times in TS buffer (10 mM Tris, 154 mM 
NaCl, pH 7.4). Membranes were then incubated overnight at 4°C with rabbit Vpma-
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specific antibodies previously described (8), washed three times in TS buffer containing 
0.05% Tween® 20 (Roth) and then incubated for 1 h at 25°C in 1:2000 dilution of swine 
anti-rabbit IgG conjugated to horseradish peroxidase (Dako). After three washes, the 
colony blots were developed for 15–30 min in 4-chloro-1-naphtol and 0.02% hydrogen 
peroxide. The reaction was stopped by washing the blots in sterile distilled water.  
Proteins that partitioned into Triton-Tx114 were extracted from 5632 as previously 
described (4), precipitated overnight at -70°C after addition of 9 volumes of cold MeOH, 
centrifugated 10 min at 12,000xg and subjected to SDS-PAGE. The gel was sliced into 
16 sections which were subjected to trypsin digestion. Peptides were further analyzed by 
nano liquid chromatography coupled to a MS/MS ion-trap mass spectrometer (LC-
MS/MS). 
Peptides were identified with SEQUEST through the Bioworks 3.3.1 interface (Thermo-
Finnigan, Torrence, CA, USA) against a database consisting of both direct and reverse 
sense Mycoplasma agalactiae strain 5632 entries (1652 entries). Using the following 
criteria (DeltaCN  0.1, Xcorr vs Charge State  1.5 (+1), 2.0 (+2), 2.5 (+3), Peptide 
Probability  0.001 and Number of Different Peptides  2) as validation filters, the False 
Positive rate is null. 
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Results and discussion voir PG2-vpma et the PG2 vpma 
Genome sequencing of strain 5632 reveals an extended vpma repertoire  
The fully sequenced genome of M. agalactiae strain 5632 revealed a total of 23 vpma 
genes (Fig. 1). In contrast to the PG2 type strain, this extended repertoire is distributed 
onto two distinct chromosomal loci, locus I and II, that contain 16 and 7 vpma genes, 
respectively. Blast analyses only identified two having significant similarity with those 
previously described in PG2 (16, 42), namely vpmaW and vpmaX, the others (vpmaA to 
vpmaG) only shared blocks of high similarity with PG2 vpmas (Fig. 2). 
More precisely, locus I5632 is 19453 bp long and is the counterpart of the PG2 vpma 
locus (Fig. 1A) because of their flanking CDS being nearly identical. In addition to 16 
vpma genes, locus I5632 contains two CDS (MAGa8140 and MAGa8130) that have no 
homology with the Vpma family but were found to have a high amino-acid similarity with 
Streptococcus agalactiae abiGI and abiGII gene products (45). The two corresponding 
genes are lacking in PG2 and were designated here as abiGI and abiGII, respectively. 
Locus I5632 further differs from its PG2 counterpart by the presence of an Insertion 
Sequence (IS) corresponding to the previously described ISMag1 (31). This IS element 
is immediately adjacent to the 3' end of the integrase-recombinase xer1 gene, whose 
product is identical to that of PG2. 
The second vpma locus of 5632, locus II5632, is 8462 kb long and contains only 7 vpma 
genes clustered between two ISMag1 copies, themselves flanked by a 16S rRNA gene 
at the 5’ end and by a CDS annotated as a hypothetical protein (HP, MAGa5900) at the 
3’ end. In PG2, this region is highly conserved except that it does not contain any IS 
element or vpma or any other gene (locus IIPG2, Fig. 1C and below). DNA blast analyses 
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of locus II5632 demonstrated that all seven vpma coding sequences are identical to seven 
vpma genes of locus I5632 (see asterisks in Fig. 1B). Interestingly, an identical xer1 gene 
also occurs at both vpma loci of 5632. Since a single functional gene would be sufficient 
to generate DNA rearrangements in each locus, the duplication was further confirmed by 
PCR to rule out any possible artefact of sequence assembling. This was performed 
using a xer1-specific primer in combination with a primer specific of the 3' region of locus 
I, phydR, or of locus II, agpR (Fig. 1D).  
The Vpma repertoire is composed of common and distinct structures 
Detailed analyses of the 23 vpma coding regions of 5632 showed that (i) two are allelic 
versions of PG2 vpma genes (vpmaW and vpmaX), (ii) 7 are duplicated (vpmaA, B, C, 
D1, D2, E and F1) and distributed in two vpma loci that are 250 kbp apart, and (iii) two 
are allelic copies of vpmaD (D1 and D2) and vpmaF (F1 and F2) that mainly vary in the 
number of their C-terminal repeated motifs. Consequently, strain 5632 contains 12 new, 
distinct Vpma products when compared to PG2 (Fig. 2). All vpma gene products encode 
a conserved amino-acid signal sequence at their N-termini followed by a lipobox and by 
a 11 amino-acids conserved sequence (41). Within 5632, some mature vpma gene 
products are unique (VpmaA, G, W) while others share blocks of amino-acids between 
them (VpmaB, C, D1, D2, E, F1, F2, H, I, J, K, L, X). Also, most Vpmas contains amino-
acid blocks that are directly repeated (VpmaA, B, D1, D2, I, F1, F2, G, W). These data 
indicate that the diversity of the Vpma family is represented by a mosaic of structures 
that is suggestive of homologous recombination events between vpma genes, gene 
duplication and/or insertion-deletion of repeated motifs. For instance, VpmaF1 and 
VpmaF2 share a common block of 104 amino-acids with VpmaK and VpmaX and, a 
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common block of 85 amino-acids with VpmaY not found in VpmaK or VpmaX. Some 
Vpma genes such as VpmaD1 and D2 or VpmaF1 and F2 represent size variants of a 
same Vpma, with a variable number of repeated motifs at their C-termini (i.e. VpmaD1 
and D2 contain respectively 20 and 2 repeated motifs of 15 amino-acids). Additionally, 
VpmaI may have a common ancestor with VpmaD1 and D2 and can be seen as the 
result of combined events such as gene duplication followed by sequence drift and/or 
repeat expansion at the 3' end.  
Anti-VpmaW and anti-VpmaY rabbit antibodies previously produced against Vpma 
products of strain PG2 (8) also reacted with 5632 surface exposed epitopes in colony 
immunoblotting (Fig. 1) and revealed the presence of sectored colonies characteristic of 
high-frequency variation in expression. Most likely, 5632 Vpmas recognised by these 
antibodies correspond to VpmaW and to VpmaF1 and/or F2 that share blocks of amino 
acids with PG2 VpmaY (Fig. 2). 
To better define the Vpma products expressed by 5632, proteins that partitioned in 
Triton X-114 detergent were subjected to SDS PAGE followed by in-gel trypsin digestion 
and by LC-MS/MS. Results showed that at least two specific peptides were detected for 
13 Vpma (VpmaA, B, C, D1, E, F1, F2, G, H, I, J, X, and W) indicating that these were 
expressed by 5632 during propagation (see Table S3 in the supplemental material). 
While D1-specific peptides were detected, the expression of VpmaD2 could not be 
assessed because all VpmaD2 trypsin-peptides being also encoded in VpmaD1 or in 
VpmaI. No peptide specific of VpmaL or VpmaK was detected although each product 
possesses a long specific sequence of 225 and 129 amino acids, respectively (Fig. 2). 
Whether VpmaL or VpmaK are expressed at low level or under different conditions can 
not be ruled out. Finally, all Vpmas encoded by locus II5632 are duplicated at locus I5632 
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and consequently, their expression can not be monitored by this method or by any other 
such as Northern blot analyses because their sequences are also identical at the DNA 
level.  
The global proteomic approach taken above is qualitative and does not reflect the level 
of expression of each Vpma, two of which are predicted to be expressed at high level by 
the clonal population while others should only reflect a minority of back-switchers. In 
PG2, the vpma locus contains a unique promoter which drives the expression of the 
vpma localized immediately downstream while other vpma genes remain silent (16). 
This promoter region was more precisely defined by Flitman-Tene et al. (14) using 
primer extension and a similar sequence was detected in each locus of the strain 5632. 
Therefore, Vpma expression in 5632 is most likely driven at each locus by a single 
promoter sequence which is highly conserved between the two loci (99% nucleotide 
identity). In locus I5632, the promoter sequence is located upstream of the vpmaB gene 
while in locus II5632 it is upstream of vpmaA suggesting that these two Vpmas would be 
predominantly co-expressed by the clonal population. However, in the absence of 
specific-antibodies this hypothesis can not be tested. One interesting observation is that 
the length of a polyT tract, located between the putative -35 and -10 boxes of the vpma 
promoters, varies among the three vpma promoters sequenced and is of 14-, 15- and 
12-nt respectively for loci I of PG2 and 5632 and for locus II of 5632 (see Fig. S1 in the 
supplemental material). In other variable mycoplasma systems, i.e. the Vlp system of 
M. hyorhinis, fluctuation in the length of the polynucleotide tract between the -35 and the 
-10 boxes has been shown to affect transcription (12). Whether this is also the case for 
the M. agalactiae species and for strain 5632 in particular, cannot be currently tested 
because of the complexity of the 5632 vpma system. In PG2, DNA rearrangements are 
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mediated by Xer1 which one recognises a specific Recombination Site (RS) sequence 
located upstream of each vpma. Indeed, analysis of the 5632 and PG2 vpma loci 
revealed that a rigorously identical RS sequence is located upstream of each of the 29 
vpma genes (23 in 5632 and 6 in PG2). This suggests that each vpma loci of 5632 can 
independently undergo DNA rearrangements and that the concomitant expression of two 
distinct Vpmas is most likely to occur frequently in this strain. If so, 5632 could 
theoretically display 91 different Vpma surface configurations against only 6 in the type 
strain PG2. In parallel, additional Vpma size variations by insertion or deletion of direct 
repeats can further participate in altering surface architecture. 
Evidence for horizontal gene transfer at the vpma locus of 5632 
As mentioned earlier, M. bovis is a close relative of M. agalactiae and generates surface 
variation using a very similar genetic system designated as the vsp gene family. Both, 
the vsp and the vpma systems, have several common features: (i) vsp or vpma related 
genes are clustered in close proximity to a conserved recombinase gene (32), (ii) the 
recombination site involved in DNA rearrangements is identical except for a single 
nucleotide polymorphism that is conserved in each species, and (iii) vpma or vsp genes 
code for proteins having a signal peptide that is highly conserved between the two 
systems. Unlike PG2, vpma loci of 5632 are associated with IS elements as in M. bovis 
(23) and one, locus I5632, contains two non-vpma genes, abiGI and abiGII, that have 
86.97 and 85.15 % overall DNA identity with two M. bovis ORFs, ORF4 and ORF5, (23), 
located in vsp locus. Searching the databases revealed that abiGI and abiGII from 5632 
also match with gene products annotated as conserved hypothetical products in 
Mycoplasma mycoides subsp. mycoides biotype LC strain GM12 (22) and M. mycoides 
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subsp. mycoides SC strain PG1 (49), with more than 50% of amino-acid similarity in 
global alignment (Table 1). While abiG homologs are present  in several Gram positive 
bacteria such as Streptococcus agalactiae and S. suis (6, 45), none was found in other 
Mollicutes sequences available in the databases, which included 21 complete genomes. 
The abiGI and abiGII genes were first described in Lactococcus lactis subsp. cremoris 
UC653 (28) where they occur as an operon carried by a conjugative plasmid and confer 
resistance to phage infection in this species (29). Detection by LC/MS-MS of AbiGII-like 
specific peptides in the Triton-X114 detergent phase of 5632 indicates that the 
corresponding abiGII gene is expressed although there is no hydrophobic domain that 
could account for this partitioning. Previous attempts to define the function of abiGI and 
abiGII of Streptococcus species failed (44) and whether abiG homologues found in 
mycoplasma have a role in protecting them against phage attack remains to be 
addressed. Nevertheless, comparison of AbiGI and AbiGII amino-acid sequences by 
constructing Neighbour-Joining trees (500 bootstraps) indicates a strong relationship 
between Mycoplasma and Streptococcus sequences suggesting that their 
corresponding genes might have undergone horizontal gene transfer (see Fig. S2 in the 
supplemental material). 
To further define the occurrence of the two abi genes in M. agalactiae, a collection of 92 
strains representative of (i) various geographical areas and (ii) various histories (see 
Table S1 in the supplemental material) was screened by PCR for the presence of abiG 
genes using specific primer pairs, aip1F/aip1R and aip2F/aip2R. PCR products 
corresponding to each gene were obtained for 11 strains out of 92. Further PCR assays 
showed that, like in Streptococcus agalactiae, the two abiG genes always occur next to 
each other. Interestingly, direct genome sequencing of six abiG positive strains using 
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aip2F2 as primer shows that the abiGII gene is always associated with vpma genes. 
Because strains displaying abiG genes in their vpma loci have very different 
geographical origin (Ivory cost, Spain and France), this results raised the question of 
whether these genes have been vertically inherited from a M. agalactiae/M. bovis 
common ancestor or whether the vpma locus is a hot spot for their insertion. Since the 
vpma locus is frequently subjected to DNA rearrangements, deletion of abiG genes by 
intra-recombination, involving for instance vpma-RS sequences, may have easily 
occurred resulting in abiG negative strains.  
Plasticity of the M. agalactiae vpma loci 
To define whether the occurrence of the two vpma loci observed in 5632 is common 
among M. agalactiae strains, a PCR assay was performed with primer pairs xerF/phydR, 
xerF/agpR and Mag2F/agpR that yield amplicons corresponding to either locus I or II of 
PG2 and/or 5632. More specifically, the two pairs xerF/phydR and xerF/agpR target the 
3’ ends of the loci which are not affected by vpma rearrangements while Mag2F/agpR 
were designed to amplify a more or less empty locus II under our PCR conditions. The 
assay was conducted with the panel of 92 strains (see above). Results showed that 89 
strains produced an amplification profile identical to that obtained with PG2 while three 
showed new profiles none of which was identical to those obtained with 5632 (Fig. 3). 
Sequencing of PCR products or selected genomic regions showed that (i) strain 13628, 
like 5632, contains an IS element at locus I while displaying a locus II similar to PG2, 
and (ii) strains 13375 and 4025, like PG2, displayed no IS at locus I while locus II 
contain one or more IS but no vpma, with strain 4025 having an IS30-like inserted into 
an ISMag1. These data suggest that the occurrence of a vpma cluster at locus II is a 
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rare event and has so far only been observed in 5632, while the occurrence of vpmas at 
locus I is shared by all M. agalactiae strains tested so far. 
The presence of an ISMag1 in close proximity to the vpma locus I in 5632 is not an 
isolated event since it is shared by at least one other strain, 13628, which, unlike 5632, 
has been isolated in France in 2003 from a goat ear canal. ISMag1 belongs to the IS30 
family (31) that generates, when inserting itself into a host genome, a direct repeat that 
flanks the IS (25). Indeed, ISMag1 of locus I is flanked in 5632 and in 13628 by an 
identical 14-nt directly repeated sequence ( “b” in Fig 3) suggesting that its insertion 
most likely occurred in an ancestor common to the two strains. Interestingly, the 14-nt 
element found on each side of the IS of locus II13375 ("a" in Fig. 3) is also repeated in 
locus II5632 as if flanking the whole locus including the IS. Because no other 14-nt 
directed repeat is found in the vicinity of the two IS, this suggested the introduction of the 
vpma cluster at locus II5632 via a duplication-insertion mechanism involving a circular 
intermediate carrying a set of vpma genes together with an ISMag1 element (Fig. 4). In 
this scenario, the duplicated vpma genes would have first clustered at one end of locus I 
via a series of DNA recombination. In a second step, part of locus I including the xer1 
and ISMag1 would have been duplicated and circularized to finally recombine at locus II 
via a single cross-over between the IS elements. One argument in favour of the 
occurrence of the circular form is that a PCR product was obtained with 5632 using 
outwardly oriented primers pv1R and xerF which partial sequencing revealed the 
presence of an ISMag1 next to a sequence “c” usually found next to the promoter (Fig. 
4). Whether this result really reflects a duplication-excision event of part of the vpma 
locus I and whether the circular form can re-insert itself elsewhere in the genome have 
still to be formally demonstrated. Nevertheless, the 100% nucleotide identity observed 
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between locus I and II of 5632 indicates that this duplication event as occurred relatively 
recently. 
Conclusion 
A number of sophisticated genetic systems devoted to high frequency surface variation 
have been described in mycoplasma species. Many of these systems appear as a small 
set of species-specific genes, which are nearly identical in all the isolates and are 
clustered at one locus. The clustering of these genes has been proposed to facilitate 
recombinations which generate diversity, and theoretically a wide surface diversity can 
be produced with only few genes, particularly as they are prone to internal 
rearrangements of their sequences. Our characterization of a new set of vpma genes in 
a M. agalactiae field isolate (5632) illustrates this point. This new repertoire is far more 
complex than the one first described in the PG2 type strain and represents a mosaic of 
structures that is suggestive of homologous recombination events between vpma genes, 
gene duplication and/or insertion-deletion of repeated motifs (see Fig. S3 in the 
supplemental material). This opens the question of the true diversity in equivalent 
variable systems from mycoplasmas with apparently few variable genes, most of which 
have been sequenced from type strains. Field or clinical isolates have the potential to 
reveal a greater than suspected diversity of variable gene repertoires, which could be 
useful to design molecular probes for epidemiology studies.  
One of the most interesting finding of our study is the occurrence of duplicated vpma loci 
in strain 5632. Because one vpma locus can only express a single vpma gene per cell, 
the consequence of such event is tremendous in terms of variability because it allows 
concomitant expression and, in turns, multiplies the number of possible surface 
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combinations. Our data suggests that this situation is most likely resulting from the 
duplication of one 5632 vpmas region at a remote chromosomal position (250 kbp away) 
and that it involves IS elements. The role of such mobile genetic elements in 
chromosomal shuffling of genes encoding major surface components may have 
important evolutionary and epidemiological consequences for pathogens such as 
mycoplasmas that have a reduced genome and no cell wall.  
Finally, whether a successful vaccine strategy based on surface antigens could be 
developed for mycoplasmas is not known but this would have to take into account the 
dynamics and scope of any variable antigen gene repertoires. 
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FIG. 1. Comparison of the M. agalactiae vpma loci between the type strain PG2 
and the strain 5632. 
Schematics represent the organization of the vpma loci in a clonal variant 55.5 derived 
from PG2 (16, 42) (Panel A), and in a clonal variant c1 derived from strain 5632 (Panel 
B). Panel C presents the counterpart of locusII5632 in PG2 and shows the absence of 
vpma genes in this region. The presence of two distinct loci in 5632 was confirmed by 
PCR using primers xerF-phydR or xerF-agpR and the resulting amplicons are shown in 
Panel D. The location of the primers is indicated by arrowheads in panels A and B. 
White large arrows labelled by a letter represent Vpma CDSs. The position of the 
promoters is represented by a black arrowhead labelled with a “P”. The two non-Vpma 
related CDSs (abiGI and abiGII) are indicated by large arrows filled with a dotted 
pattern. Insertion sequence elements ISMag1 are indicated by hatched boxes. 
Recombination sites downstream of each vpma gene are indicated by a black dot. An 
asterisk (*) indicates that the corresponding vpma gene is present at two distinct loci. 
Schematics were approximately drawn to scale. HP: hypothetical protein; CHP: 
conserved hypothetical protein. Small letters and bars indicate the position of short 
particular sequences mentioned in the text and in Fig. 3 and 4.  
The pictures on the left side of Panel A and B illustrate the variable surface expression 
of Vpma as previously described (8, 17). These correspond to colony immunoblot using 
Vpma-specific pAb recognizing PG2 VpmaW ( W) and VpmaY ( Y) epitopes. 
 
FIG. 2. Structural features and comparison of vpma gene products in M. agalactiae 
strain PG2 and 5632. 
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Predicted Vpma proteins are schematically represented by boxes and begin with a 
homologous 25-aa leader sequence (black boxes) followed by regions that have 
homology between vpma gene products or that are repeated within a same product 
(coloured boxes). Two boxes of a same colour display an amino acid identity > 30%. 
White boxes represent unique sequences. Numbers below boxes indicate the number of 
amino-acids. For 5632, detection by MS/MS of expressed Vpma specific peptides is 
noted by +; – indicates that no specific peptides were detected for the corresponding 
Vpma. For VpmaD2, +# indicates that VpmaD2 peptides detected are not specific 
because all are shared with D1 or I (see the list of detected peptides in Table S3 in the 
supplemental material). An asterisk (*) indicates that the corresponding vpma gene is 
present in 5632 at both vpma loci. 
 
FIG. 3. Comparison of vpma loci or their counterparts in M. agalactiae strains PG2 
55.5, 5632 c1, 13628, 13375 and 4025. 
Pictures represent the amplification of locus I and/or II using primers xerF/phydR, 
xerF/agpR and Mag2F/agpR which positions are indicated in the schematics below by 
arrow heads. Schematics represent the vpma locus I and the vpma locus II or 
counterpart. Brackets indicate the vpma genes cluster localization next to the xer1 gene 
(filled black arrow). Insertion elements (ISMag1 or IS30-like) are indicated by shaded 
boxes. Lines traced between primers symbolise PCR amplicons obtained with an 
asterisk (*) indicating those which have been directly sequenced. White bars below the 
loci indicate regions that were directly sequenced using genomic DNA.  Small letters (a, 
b, c and d) represent the 14-nt sequences that flanked the IS.  
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FIG. 4. Scenario of duplication-insertion of 5632 vpma genes, from locus I to locus 
II via a circular intermediate 
Schematics illustrate the putative scenario in which the vpma cluster of 5632 at locus II 
originates from locus I by a mechanism of duplication-insertion involving a circular 
intermediate and IS elements. 
Small bars with a letter below represent 14-nucleotides sequences (a, b, c) flanking the 
ISMag1 either after insertion event (a, b) or after homologous recombination event (c). 
The dotted arrow indicates the clustering process of seven vpma gene at one end of the 
locus I starting from the current configuration. It represents a series of an unknown 
number of possible DNA rearrangements.   Asterisk (*) indicates duplicated vpmas. 
The picture shows the PCR amplification of the circular intermediate obtained when 
using primers xerF and pv1R and 5632 crude DNA extract as template. 
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TABLE 1. Analyses of abiG related genes products in mollicutes and other 
bacteria 
 
Mycoplasma agalactiae strain 5632 
 
AbiG I-like (MAGa8140) AbiG II-like (MAGa8130) 
M. agalactiae PG2 - - 
M. bovis PG45 + (84.8% ; 93.6%) + (81.1% ; 91.3%) 
M. mycoides mycoides SC PG1 + (40.8% ; 59.2%) + (41.8% ; 64.6%) 
M. mycoides mycoides LC GM12 Mmycm_04185 + (41.7% ; 
59.2%) 
Mmycm_00130 + (40.1% ; 
58.5%) 
Mmycm_04180 + (31.9% ; 
51.6%) 
Mmycm_00135 + (32.6% ; 
50.9%) 
Other Mollicutes - - 
Streptoccus agalactiae H36B + (40.2% ; 58.3%) + (41.2% ; 65.3%) 
Streptococcus suis 05ZYH33 + (41.2% ; 58.3%) + (40.4% ; 66.3%) 
Other than Streptococcus sp. + (<40% ; na) + (<40%) 
 
 (+): presence of homologous sequence; (-): absence of homologous sequence in public 
databases (june 2008); identity and similarity percentages between amino-acid 
sequences are respectively indicated in brackets and were obtained using the Needle 
alignment program (http://mobyle.pasteur.fr/Mobyle/programs/needle.xml). 
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25 60 27 5916 27 59 27 51
VpmaU L
25 60 2716 27 18 65
VpmaZ L RZ1 RZ2
25 25 6817 18 68 110
VpmaX L
25 104 6824
VpmaY L RY1 RY2
25 1048510428
RW1 RW2’LVpmaW
25 36 90 8011
VpmaX L
25 104 6829
VpmaL L
25 27 22516
Vpma PG2
Vpma 5632
Figure 2
Identified as 
expressed by MS/MS
RD2021’
7
+
+
+
+
+#
+
+
+
+
+
-
+
+
+
+
-
4025
13375
13628
5632
PG2
Locus  IILocus I
16S HP
Mag2F agpR
16S HP
Mag2F agpR
16S HP
ISMag1
a a
agpRMag2F
16S HP
IS30-like
d d
agpRMag2F
xer 116S HP
ISMag1 ISMag1
a ab
xerF agpR
vpmas
Mag2F
xer 1 CHP
xerF phydR
vpmas
tRNALys
xer 1 CHP
ISMag1
bb
xerF phydR
vpmas
tRNALys
xer 1 CHP
600
ISMag1
bb
xerF phydR
vpmas
tRNALys
xer 1 CHP
xerF phydR
vpmas
tRNALys
xer 1 CHP
xerF phydR
vpmas
tRNALys
*
Figure 3
*
*
MPG
2
56
32
13
62
8
13
37
5
40
25
PG
2
56
32
13
62
8
13
37
5
40
25
locus II
xerF/agpR
locus II
Mag2F/agpR
locus I
xerF/phydR
PG
2
56
32
13
62
8
13
37
5
40
25
M
c
ISMag1ISMag1 P
xer1
D2F1ED1CA B16S23S 16S23S
a ac b
ISMag1
a a
16S23S
1. Clustering of duplicated vpma genes
2. Duplication 
and circularisation
3. Insertion by homologous
recombination at locus II
P
xer1
D1LKJF1ID2AECW BXF2G H
tRNALys
P
*** * * * *
locus I5632
locus II5632
5632
N
eg.
Ctrl
2.5kb
M
xer1
7 vpma
genes
xerF
ISMag1
b c
pv1
R
P
Figure 4
* * * * * * *
* * * * * * *
ISMag1ISMag1
ISMag1
b bc
c b b
xerFpv1R
CLUSTAL W (1.83) multiple sequence alignment
__-35__ _____polyT_____ __-10__     +1 
I-5632          CAAAAAATTTTTGCTATTTTTTTTTTTTTTTATATAATGTTGTCATCTATTGATGAATAT
II-5632         CAAAAAATTTTTGCTATTTTTTTTTTTT---ATATAATGTTGTCATCTATTGATGAATAT
PG2             CAAAAAATTTTTGCTATTTTTTTTTTTTTT-ATATAATATTGTCATCTATTGATGAATAT
****************************   ******* *********************
I-5632          ATTAAGCGCTAAAAAACTACATACAACTTCATAA--------GTTGTAATCAGTGGCAGA
II-5632         ATTAAGCGCTAAAAAACTACATACAACTTCATAA--------GTTGTAATCAGTGGCAGA
PG2             ATTAAGCGCTAAAAAACTACATGCAACTTGATAACTTGATAAGTTGCAATTAGTAGAAGA
********************** ****** ****        ******** *** * ***
I-5632          TTGTAGCGTTTTAATTAAATGGCTTAAATTTGCTATTAATTTAGCACTTAATGCATCATA
II-5632         TTGTAGCGTTTTAATTAAATGGCTTAAATTTGCTATTAATTTAGCACTTAATGCATCATA
PG2             TTGTAGCGTTTTAATTAAATGGCTTAA-TTTGCTATTAATTTAGCACTTAATACATCATA
*************************** ************************ *******
I-5632          TAATAAATTGATATTTATTAATAGATTTATAAAGCATTTTTAAGGCTATTTTATAGCTTT
II-5632         TAATAAATTGATATTTATTAATAGATTTATAAAGCATTTTTAAGGCTATTTTATAGCCTT
PG2             TAATAAATTGATATTTATTAATAGATTTATAAAGCATTTTTAAGGCTATTTTATAGCCTT
************************************************************
I-5632          TAAAGAAAGGATAAATTTATG
II-5632         TAA-GAAAGGATAAATTTATG
PG2             TAAAGAAAGGATAAATTTATG
*** *****************
FIG. S1. Multiple sequence alignment of vpma promoter regions 
in PG2 and 5632 loci I and II
Promoter region sequences, from -35 box to ATG start codon, of the 
three PG2 and 5632 vpma loci were aligned using ClustalW
(http://mobyle.pasteur.fr/Mobyle/programs/clustalw.xml) Blue shading 
indicates the variable polyT stretches existing between -35 and -10 
boxes shaded in dark grey.
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FIG. S2. AbiGI-like and AbiGII-like phylogenetic trees
Neighbour-joining tree based on AbiGI-like (A) and AbiGII-like (B) homologous gene 
products among Mycoplasma and Streptoccocus genus. AbiEI (A) and AbiEII (B) 
sequences encoded by pNP40 plasmid genes of Lactococcus lactis serve as the 
outgroup. Two AbiG-like pair of homologues present in Mycoplasma mycoides subsp. 
mycoides LC strain GM12, (a) and (b) annotations differentiate each pair. Bootstrap 
supporting values after 500 replicates are indicated. Sequence accession numbers: (A), 
NP_975179, ZP_02512914, ZP_02511961, AAK94955, YP_001198332, ZP_00783155, 
YP_001966453; (B), NP_975178, ZP_02512913, ZP_02511962, AAK94954, 
YP_001198333, ZP_00783153, YP_001966452.
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FIG. S3. Imaging of whole sequence comparison between PG2 vpma locus and 
5632 vpma locus I
Screenshot image obtain with Artemis comparison tool. Homologies between the two 
genome portions are represented by coloured boxes correspond to single match, with red 
representing a good match between positive strands and blue between negative strands. 
An example of the redundancy of the recombination site (RS) is illustrated in yellow, and 
shows the identity of PG2 RS with those of locus I of 5632. As well, the match between 
the xer1 genes is also shown in yellow.
